$CALM

Maybe There Was an Egg Cartel After All

Egg prices in the U.S. surged in 2022, initially attributed to bird flu. However, federal investigators allege that Cal-Maine, Hickman's, and Versova coordinated to artificially inflate prices through surplus bids. Prices rose 120% by December. Cal-Maine, a publicly traded company, cited the flu in its investor announcement. Antimonopoly group Farm Action questioned the price hikes, noting flock sizes didn't justify the increase.

Original reporting
Published Oct 18, 2026, 11:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 18, 2026, 11:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Maybe There Was an Egg Cartel After All — source image
Decision brief

The 30-second read

$CALMBearishMed
01

Why it matters

Regulatory scrutiny introduces legal risk, potential fines, and reputational damage, likely pressuring Cal-Maine's share price.

02

Market read

First report of a major antitrust probe into the egg industry, creating new risk for Cal-Maine and possibly the broader agribusiness sector.

03

What to watch

The impact of bird flu on supply may offset price-fixing concerns, sustaining demand-driven price support.

Relevance 7/10Novelty 7/10Timing: today

Background

The article details a DOJ investigation into alleged price-fixing by Cal-Maine, Hickman's Egg Ranch, and Versova, describing coordinated bidding on the Egg Clearinghouse.

Company-level read

Ticker impact

$CALMBearishHigh confidence
Context

U.S. Justice Department alleges Cal-Maine coordinated price-fixing in the egg market, exposing the company to legal risk and potential fines.

Expected impact

likely pressure as market prices in regulatory risk.

Evidence & confidence

Antitrust allegations can lead to fines, reputational damage, and increased scrutiny, which typically depresses share price.

Market effects

Potentially raises scrutiny on other large agribusinesses and could trigger broader sector risk for food producers.

May affect egg price dynamics in U.S. regional markets as suppliers adjust to legal exposure.

Limited to U.S. markets but could influence global commodity pricing perceptions.

Counterpoint

If the investigation stalls, Cal-Maine could emerge unscathed and benefit from reduced competition.

Key entities

  • Cal-Maine Foods

    Largest publicly traded U.S. egg producer, ticker CALM.

  • U.S. Justice Department

    Antitrust division leading the investigation.

Related articles

$FRPTMed

Perishable Food Q2 Earnings: Mission Produce (NASDAQ:AVO) is the Best in the Biz

Freshpet (FRPT) reported Q2 revenue of $305.6M, up 15.5% YoY, beating estimates. Cal-Maine (CALM) saw revenue drop 41.5% YoY to $539.6M, missing expectations. Pilgrim's Pride (PPC) reported $4.63B revenue, down 2.8% YoY, also missing estimates. United Natural Foods (UNFI) reported flat revenue at $7.64B, slightly missing expectations. All stocks except UNFI are down since reporting.

$CALMMed

Cal-Maine Foods (CALM), Why Is It Back In Focus Today?

Cal-Maine Foods (CALM) reported a first-quarter net loss of $58.62M, down from a profit a year ago, with sales at $539.61M. The stock has declined 10.67% over 30 days and 21.94% over 90 days, but remains up 64.84% and 149.34% over three and five years. The company is expanding specialty egg and prepared foods offerings, aiming for higher margins. Analysts estimate a fair value of $68.33, with the stock currently trading at $66.67. Risks include avian influenza and oversupply pressures.

$CALMMedAI 8/10

Is Cal-Maine’s (CALM) Egg Slump Already Priced Into the Stock?

Cal-Maine Foods (CALM), the largest US egg producer, reported a weak Q1 FY2027 with net sales down 41.5% to $539.6M and a net loss of $58.6M. Specialty eggs and prepared foods, now 54.1% of sales, remained profitable. Retail demand for specialty eggs and exports rose, while supply may be tightening. Management is expanding prepared foods capacity. Conventional eggs, still dominant, saw a 59.5% sales drop due to price declines.

$CALMMed

Will Wider Quarterly Loss Change Cal Maine Foods' (CALM) Narrative

Cal-Maine Foods reported Q1 2027 sales of $539.61M and a net loss of $58.62M, both down year-over-year. Lower demand and pricing for conventional shell eggs impacted profitability, leading to a suspended dividend. The company continued share repurchases and rolled out Amino to improve data flows, focusing on operational efficiency. Investors now assess the impact of these results on the company's investment narrative, with a P/E of 53x and execution risks highlighted.

$CALMHigh

Egg prices are falling, and the nation’s top producer is paying the price

Cal-Maine Foods Inc. reported a 42% drop in net sales for its fiscal first quarter, with prices falling due to oversupply. The company posted a $59 million net loss. Shares fell 7.4%. According to the US Bureau of Labor Statistics, large grade A shell eggs averaged $2.272 a dozen in August. The company will not pay a cash dividend. U.S. egg output and laying flock increased year-over-year in August, but egg chicks placed for future hatchery supplies dropped 7%.